NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	40,783	40,783	44,319	40,020	27,085	19,462
Revenue Growth	-7.98%	-7.98%	10.74%	47.76%	39.17%	-5.34%
Gross Profit Gross Profit Growth	33,878	33,878	37,045	32,533	20,541	13,617
Operating Income Operating Income Growth	12,299	12,299	19,662	15,706	8,098	1,234
Net Income Net Income Growth	14,185	14,185	18,854	13,883	7,153	1,700
Earnings Per Share EPS Growth	79.20	79.20	105.26	77.34	39.18	9.32
EPS Growth	-24.76%	-24.76%	36.10%	97.40%	320.39%	-61.42%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Pharmaceuticals Pharmaceuticals Growth	39,401	39,401	43,689	38,905	26,662	19,399
Agro Chemicals Agro Chemicals Growth	1,382	1,382	606	1,083	409	49
Total Total Growth	40,783	40,783	44,295	39,988	27,071	19,448

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	21,291	21,291	24,899	13,912	7,931	7,599
Total Debt Total Debt Growth	7,139	7,139	2,794	3,861	1,761	4,320
Net Cash (Debt) Net Cash Growth	14,152	14,152	22,105	10,051	6,170	3,279
Net Cash Growth	-35.98%	-35.98%	119.93%	62.90%	88.17%	-38.57%
Net Cash Per Share Net Cash Per Share Growth	79.02	79.02	123.42	56.00	33.80	17.98

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	17,683	17,683	16,968	12,116	8,491	465
Capital Expenditures CapEx Growth	-3,883	-3,883	-4,011	-3,394	-1,463	-2,328
Free Cash Flow Free Cash Flow Growth	13,800	13,800	12,957	8,722	7,028	-1,863
Free Cash Flow Growth	6.51%	6.51%	48.55%	24.10%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	83.07%	83.07%	83.59%	81.29%	75.84%	69.97%
Operating Margin	30.16%	30.16%	44.37%	39.25%	29.90%	6.34%
Pretax Margin	37.70%	37.70%	51.70%	41.82%	31.82%	10.39%
Profit Margin	34.78%	34.78%	42.54%	34.69%	26.41%	8.73%
FCF Margin	33.84%	33.84%	29.24%	21.79%	25.95%	-9.57%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	5.000	5.000	6.000	9.500	5.500	4.500
Dividend Per Share Growth	-16.67%	-16.67%	-36.84%	72.73%	22.22%	-14.29%
Dividend Yield	0.55%	0.51%	0.76%	1.01%	1.00%	0.61%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	11.58	12.30	7.59	12.28	14.37	81.18
Forward PE	22.75	20.41	7.58	11.66	10.02	16.05
P/FCF Ratio	11.90	12.64	11.04	19.55	14.63	-
PS Ratio	4.03	4.28	3.23	4.26	3.80	7.09

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error